Literature DB >> 32699180

Dietary sodium restriction decreases urinary NGAL in older adults with moderately elevated systolic blood pressure free from chronic kidney disease.

Wei Wang1, Michel Chonchol1, Douglas R Seals2, Kristen L Nowak3.   

Abstract

Increased aortic stiffness may contribute to kidney damage by transferring excessive flow pulsatility to susceptible renal microvasculature, leading to constriction or vessel loss. We previously demonstrated that 5 weeks of dietary sodium restriction (DSR) reduces large-elastic artery stiffness as well as blood pressure in healthy middle-aged/older adults with moderately elevated systolic blood pressure (SBP) who are free from chronic kidney disease (CKD). We hypothesized that DSR in this cohort would also reduce urinary concentrations of renal tubular injury biomarkers, which predict incident CKD in the general population. We performed a post hoc analysis using stored 24 hours urine samples collected in 13 participants as part of a randomized, double-blind, crossover clinical trial of DSR (low sodium (LS) target: 50 mmol/day; normal sodium (NS) target: 150 mmol/day). Participants were 61±2 (mean±SEM) years (8 M/5 F) with a baseline blood pressure of 139±2/82±2 mm Hg and an estimated glomerular filtration rate of 79±3 mL/min/1.73 m2 Twenty-four hour urinary sodium excretion was reduced from 149±7 to 66±8 mmol/day during week 5. Despite having preserved kidney function, participants had a 31% reduction in urinary neutrophil gelatinase-associated lipocalin concentrations with just 5 weeks of DSR (LS: 2.8±0.6 vs NS: 4.2±0.8 ng/mL, p<0.05). Results were similar when normalized to urinary creatinine (urinary creatinine did not change between conditions). Concentrations of another kidney tubular injury biomarker, kidney injury molecule-1, were below the detectable limit in all but one sample. In conclusion, DSR reduces an established clinical biomarker of kidney tubular damage in adults with moderately elevated SBP who are free from prevalent kidney disease. © American Federation for Medical Research 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  hypertension; kidney; sodium; vascular stiffness

Year:  2020        PMID: 32699180      PMCID: PMC7531580          DOI: 10.1136/jim-2020-001343

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  44 in total

1.  A randomized trial of dietary sodium restriction in CKD.

Authors:  Emma J McMahon; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; David W Johnson; Katrina L Campbell
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

2.  Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.

Authors:  Eugenia Singer; Antje Elger; Saban Elitok; Ralph Kettritz; Thomas L Nickolas; Jonathan Barasch; Friedrich C Luft; Kai M Schmidt-Ott
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

3.  A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.

Authors:  Rajiv Saran; Robin L Padilla; Brenda W Gillespie; Michael Heung; Scott L Hummel; Vimal Kumar Derebail; Bertram Pitt; Nathan W Levin; Fansan Zhu; Samer R Abbas; Li Liu; Peter Kotanko; Philip Klemmer
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 8.237

4.  Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Authors:  Chi-Yuan Hsu; Dawei Xie; Sushrut S Waikar; Joseph V Bonventre; Xiaoming Zhang; Venkata Sabbisetti; Theodore E Mifflin; Josef Coresh; Clarissa J Diamantidis; Jiang He; Claudia M Lora; Edgar R Miller; Robert G Nelson; Akinlolu O Ojo; Mahboob Rahman; Jeffrey R Schelling; Francis P Wilson; Paul L Kimmel; Harold I Feldman; Ramachandran S Vasan; Kathleen D Liu
Journal:  Kidney Int       Date:  2016-10-28       Impact factor: 10.612

5.  Urinary Sodium and Potassium Excretion and CKD Progression.

Authors:  Jiang He; Katherine T Mills; Lawrence J Appel; Wei Yang; Jing Chen; Belinda T Lee; Sylvia E Rosas; Anna Porter; Gail Makos; Matthew R Weir; L Lee Hamm; John W Kusek
Journal:  J Am Soc Nephrol       Date:  2015-09-17       Impact factor: 10.121

6.  Tubular kidney injury molecule-1 (KIM-1) in human renal disease.

Authors:  M M van Timmeren; M C van den Heuvel; V Bailly; S J L Bakker; H van Goor; C A Stegeman
Journal:  J Pathol       Date:  2007-06       Impact factor: 7.996

7.  Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.

Authors:  M R Weir; D R Dengel; M T Behrens; A P Goldberg
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

8.  Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more.

Authors:  Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2009-03-23       Impact factor: 5.992

Review 9.  Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.

Authors:  Lanfranco D'Elia; Giovanni Rossi; Michele Schiano di Cola; Ivana Savino; Ferruccio Galletti; Pasquale Strazzullo
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-03       Impact factor: 8.237

10.  A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients.

Authors:  Katrina L Campbell; David W Johnson; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; Jonathan P Whitehead; Goce Dimeski; Emma McMahon
Journal:  BMC Nephrol       Date:  2014-04-04       Impact factor: 2.388

View more
  1 in total

1.  High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults.

Authors:  Alex M Barnett; Matthew C Babcock; Joseph C Watso; Kamila U Migdal; Orlando M Gutiérrez; William B Farquhar; Austin T Robinson
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.